Related Experiment Video
Updated: Jun 28, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Nucleotide excision repair and anti-cancer chemotherapy
1Division of Clinical Sciences, National Cancer Institute, Building 10, Room 12N226, Bethesda, MD, 20892, U.S.A. E-mail, reed92@helix.nih.gov.
Abstract:
DNA repair is an important effector of anti-cancer drug resistance. In recent years, it has become apparent that DNA repair is an extremely complex process. Processes within DNA repair that may contribute to one or more drug resistance phenotypes include; O-6-alkyltransferase activity, base excision repair, mismatch repair, nucleotide excision repair, and gene specific repair. Clearly, several of these processes may show increased activity within any single cell, or tumor, at any one time. This review attempts to touch briefly upon the question of the distinctions between each of these specific pathways; and then seeks to expand on nucleotide excision repair as a possible effector of cellular and clinical resistance to platinum-based anticancer therapy.
Insights
DNA repair mechanisms, including nucleotide excision repair, are key to anti-cancer drug resistance. Understanding these complex pathways is crucial for developing effective cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DNA repair is a critical factor in the development of resistance to anti-cancer drugs.
- Several DNA repair pathways, including O-6-alkyltransferase activity, base excision repair, mismatch repair, nucleotide excision repair, and gene-specific repair, can contribute to drug resistance phenotypes.
- The interplay and increased activity of these pathways within a single cell or tumor can significantly impact treatment outcomes.
Purpose of the Study:
- To briefly review the distinctions between various DNA repair pathways.
- To expand on the role of nucleotide excision repair (NER) in cellular and clinical resistance to platinum-based anticancer therapies.
Main Methods:
- Literature review of DNA repair mechanisms.
- Focus on nucleotide excision repair pathways and their clinical relevance.
Main Results:
- DNA repair is a complex, multi-pathway process contributing to drug resistance.
- Increased activity in specific repair pathways can lead to treatment failure.
Conclusions:
- Nucleotide excision repair is a significant effector of cellular and clinical resistance to platinum-based anticancer drugs.
- Further research into NER and other DNA repair pathways is essential for overcoming drug resistance in cancer treatment.
Related Concept Videos
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Base Excision Repair
The first step of...
Base Excision Repair
The first step of...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
